{"id":"https://openalex.org/W2086587154","doi":"https://doi.org/10.1089/jir.1980.1.95","title":"Use of Human Fibroblast-Derived (Beta) Interferon in the Treatment of Epidemic Adenovirus Keratoconjunctivitis","display_name":"Use of Human Fibroblast-Derived (Beta) Interferon in the Treatment of Epidemic Adenovirus Keratoconjunctivitis","publication_year":1980,"publication_date":"1980-01-01","ids":{"openalex":"https://openalex.org/W2086587154","doi":"https://doi.org/10.1089/jir.1980.1.95","mag":"2086587154","pmid":"https://pubmed.ncbi.nlm.nih.gov/6180050"},"language":"en","primary_location":{"id":"doi:10.1089/jir.1980.1.95","doi":"https://doi.org/10.1089/jir.1980.1.95","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.1980.1.95","pdf_url":null,"source":{"id":"https://openalex.org/S2755320784","display_name":"Journal of Interferon Research","issn_l":"0197-8357","issn":["0197-8357","2332-4007"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111796415","display_name":"A. Romano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. ROMANO","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111441256","display_name":"M Revel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. REVEL","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059662776","display_name":"Dalia Gurari-Rotman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. GUARARI-ROTMAN","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. BLUMENTHAL","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. BLUMENTHAL","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110271136","display_name":"Robert Benjamin Stein","orcid":"https://orcid.org/0009-0007-9133-168X","observed_orcids":["https://orcid.org/0009-0007-9133-168X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. STEIN","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7419,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.73497537,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"1","issue":"1","first_page":"95","last_page":"100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.9189000129699707,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.9189000129699707,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.06369999796152115,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epidemic-keratoconjunctivitis","display_name":"epidemic keratoconjunctivitis","score":0.8690000176429749},{"id":"https://openalex.org/keywords/adenovirus","display_name":"adenovirus","score":0.875},{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.6919999718666077},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.8889999985694885},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.6740000247955322},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.64764803647995},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.6133948564529419},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6104062795639038},{"id":"https://openalex.org/C2780381497","wikidata":"https://www.wikidata.org/wiki/Q463418","display_name":"Fibroblast","level":3,"score":0.46608465909957886},{"id":"https://openalex.org/C2778064476","wikidata":"https://www.wikidata.org/wiki/Q1623006","display_name":"Keratoconjunctivitis","level":2,"score":0.43341416120529175},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4281920790672302},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.4205552339553833},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4135338068008423},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3696792423725128},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3391050696372986},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3388362526893616},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2803504168987274},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1375349760055542},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12546193599700928},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000257","descriptor_name":"Adenoviridae Infections","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D000258","descriptor_name":"Adenovirus Infections, Human","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007634","descriptor_name":"Keratitis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007634","descriptor_name":"Keratitis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D007637","descriptor_name":"Keratoconjunctivitis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012709","descriptor_name":"Serum Albumin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/jir.1980.1.95","doi":"https://doi.org/10.1089/jir.1980.1.95","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.1980.1.95","pdf_url":null,"source":{"id":"https://openalex.org/S2755320784","display_name":"Journal of Interferon Research","issn_l":"0197-8357","issn":["0197-8357","2332-4007"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon Research","raw_type":"journal-article"},{"id":"pmid:6180050","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6180050","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of interferon research","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W40421884","https://openalex.org/W1535162010","https://openalex.org/W1981259985","https://openalex.org/W1997211166","https://openalex.org/W2004662736","https://openalex.org/W2008419769","https://openalex.org/W2031204443","https://openalex.org/W2047605937","https://openalex.org/W2163308777","https://openalex.org/W2314006877","https://openalex.org/W2885604409"],"related_works":["https://openalex.org/W2417540740","https://openalex.org/W2403405479","https://openalex.org/W2068303759","https://openalex.org/W7024839981","https://openalex.org/W1491001334","https://openalex.org/W583673161","https://openalex.org/W1966735345","https://openalex.org/W2171213247","https://openalex.org/W58058599","https://openalex.org/W1986657937"],"abstract_inverted_index":{"Topical":[0],"application":[1],"of":[2,13,23,29,58,66,79,87,95,104,124],"human":[3,46],"fibroblast-derived":[4],"(beta)":[5],"interferon":[6,125],"(HulFN-beta)":[7],"has":[8],"been":[9],"used":[10],"in":[11,73,97,109,119],"treatment":[12],"epidemic":[14],"keratoconjunctivitis":[15],"due":[16],"to":[17,63,90,113,117,137],"adenovirus.":[18],"Patients":[19],"received":[20,39],"a":[21,43,64,102],"total":[22],"1-2":[24],"x":[25,129],"10(5)":[26],"reference":[27],"units":[28,131],"HulFN-beta":[30],"per":[31,132],"day,":[32,133],"divided":[33],"into":[34],"8-10":[35],"drops.":[36],"Control":[37],"patients":[38],"corticosteroid":[40],"therapy":[41],"or":[42],"placebo":[44],"containing":[45],"serum":[47],"albumin,":[48],"with":[49],"the":[50,74,77,80,105,110,120],"same":[51],"administration":[52],"schedule.":[53],"The":[54,69,93],"severity":[55],"and":[56],"evolution":[57],"symptoms":[59],"was":[60,82,107],"analyzed":[61],"according":[62],"number":[65,94],"clinical":[67],"criterias.":[68],"results":[70],"indicate":[71],"that":[72],"interferon-treated":[75,111],"group":[76,112],"length":[78],"disease":[81,106],"reduced":[83,108],"from":[84],"an":[85],"average":[86],"27":[88],"days":[89],"6.5":[91],"days.":[92],"cases":[96],"which":[98],"keratitis":[99],"occurred":[100],"as":[101,115],"complication":[103],"10%,":[114],"opposed":[116],"57%":[118],"control":[121],"group.":[122],"Doses":[123],"lower":[126],"than":[127],"5":[128],"10(4)":[130],"were":[134],"not":[135],"effective":[136],"prevent":[138],"keratitis.":[139]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}